$ADPT (Adeptus Health Inc.)

$ADPT {{ '2016-09-07T20:16:01+0000' | timeago}} • Announcement

$ADPT said Thomas Hall has informed the BoD of his intention to retire as CEO. To ensure an orderly transition, Hall plans to continue as CEO until earlier of mid-2017 or appointment of his successor. Hall has also agreed to remain on the Board as Chairman through his current term, which ends at $ADPT's 2017 Annual Meeting.

$CYH {{ '2017-07-24T10:52:14+0000' | timeago}} • Announcement

$CYH's subsidiaries agreed to sell 126-bed Highlands Regional Medical Center in Sebring, Florida, and its associated assets to subsidiaries of $HCA. The transaction is expected to close in the fall of 2017.

$HCA {{ '2017-07-21T20:39:36+0000' | timeago}} • Announcement

$HCA has agreed to acquire Highlands Regional Medical Center in Sebring, Florida, from subsidiaries of Community Health Systems, Inc. The transaction, which is subject to regulatory approvals and other closing conditions, is expected to close in the fall of 2017.

$REGN {{ '2017-07-21T15:50:38+0000' | timeago}} • Announcement

$REGN and $SNY announced that the European Medicine Agency's Committee for Medicinal Products for Human Use has given a positive opinion for the marketing authorization of Dupixent (dupilumab), recommending its approval in Europe for use in adults with moderate-to-severe atopic dermatitis who are candidates for systemic therapy.

$ABT {{ '2017-07-20T19:55:45+0000' | timeago}} • Webcast

For 3Q17, $ABT expects adjusted EPS of $0.64-0.66, with operational sales growth expected in the mid-single digits. At current exchange rates, the company expects operational sales growth to have a negative YoY impact of around 0.5%.

$ABT {{ '2017-07-20T19:45:56+0000' | timeago}} • Webcast

$ABT said that on a comparable operational basis, 3Q17 Established Pharmaceuticals sales growth is expected in the high double-digit, while in Nutrition, sales growth is expected in low single-digit. In Diagnostics, $ABT expects sales to increase mid-to-high single digits and in Medical Devices, sales is expected to increase double-digits.

$ABT {{ '2017-07-20T17:49:19+0000' | timeago}} • Announcement

$ABT raised its full year profit forecast backed by the intention of closing the Alere acquisition in 2017. The company raised its FY17 adjusted earnings from continuing operations guidance by $0.03 to a range of $2.43-2.53 per share. Reported EPS forecast was also raised from the range of $0.92-1.02 to $1.03-1.13, reflecting double-digit growth.

$ABT {{ '2017-07-20T17:36:53+0000' | timeago}} • Announcement

Declining operating earnings and rising costs and expenses hit $ABT 2Q17 earnings as much as 54%. Earnings plunged to $283MM or $0.15 from $615MM or $0.40 per share a year earlier. Sales, however, surged 24.4% on St. Jude Medical acquisition. On an adjusted basis, $ABT reported EPS above its previous guidance range at $0.62 per share.

$HLS {{ '2017-07-20T13:56:35+0000' | timeago}} • Announcement

The BoD of $HLS declared a quarterly cash dividend on its common stock of $0.25 per share. The dividend is payable on Oct. 16, 2017, to stockholders of record on Oct. 2, 2017.

$ABT {{ '2017-07-20T12:52:57+0000' | timeago}} • Infographic

$ABT Abbott Laboratories Earnings AlphaGraphic: Q2 2017 Highlights

$UHS {{ '2017-07-19T22:35:19+0000' | timeago}} • Announcement

$UHS BoD approved a cash dividend of $0.10 per share on Sept. 15, 2017 to shareholders of record as of Sept. 1, 2017.

$ABT {{ '2017-07-17T12:36:21+0000' | timeago}} • Announcement

$ABT is commencing a tender offer to purchase for cash all outstanding shares of Series B Convertible Perpetual Preferred Stock of Alere Inc. at a price of $402 per share of Preferred Stock. The offer will expire at 11:59 pm, NYC time, on Aug 11, 2017. There is no financing condition to the offer.

$ABT {{ '2017-07-13T12:23:21+0000' | timeago}} • Announcement

$ABT and Bigfoot Biomedical agreed to develop and commercialize diabetes management systems, integrating $ABT's FreeStyle Libre glucose sensing technology with Bigfoot's insulin delivery solutions in the United States. $ABT will provide Bigfoot with the next generation of its FreeStyle Libre glucose sensing technology.

$LIVN {{ '2017-07-12T12:45:32+0000' | timeago}} • Announcement

$LIVN appointed Keyna Skeffington as SVP and General Counsel. Skeffington most recently served as Vice President of Legal – Corporate and Securities, Deputy General Counsel and Assistant Secretary at $MDT.

$CYH {{ '2017-07-12T11:46:04+0000' | timeago}} • Announcement

Hospital operator $CYH said its subsidiaries have signed a definitive agreement to sell Weatherford Regional Medical Center in Texas, and its associated assets, to the subsidiaries of $HCA. The transaction is expected to close later this year. The company is planning to divest a total of 30 hospitals.

$HCA {{ '2017-07-11T22:05:57+0000' | timeago}} • Announcement

$HCA announced an agreement to acquire Weatherford Regional Medical Center outside Fort Worth, Texas, from subsidiaries of Community Health Systems, Inc. The transaction, which is subject to regulatory approvals and other closing conditions, is expected to close by the fall of 2017.

$SEM {{ '2017-07-11T15:58:57+0000' | timeago}} • Announcement

$SEM subsidiary Select Medical Corp. has opened a new rehabilitation hospital, in a joint venture partnership with SSM Health.  SSM Health Rehabilitation Hospital - Lake Saint Louis, which offers rehabilitation care for acute medical conditions, is the first such facility having a brain injury unit.

$HLS {{ '2017-07-11T10:50:33+0000' | timeago}} • Announcement

$HLS expects the total rebranding investment to be about $25-30MM, to be incurred between 2017 and 2019. About $7-10MM is expected to be incurred in 2017, of which $6-8MM will be operating expenses and $1-2MM will be capital expenditures. Only $1MM of this investment is included in 2017 forecast which will be updated in 2Q17 results.

$HLS {{ '2017-07-11T10:46:49+0000' | timeago}} • Announcement

$HLS said it will change its name to Encompass Health Corp., effective Jan. 2, 2018. The corporate name change will be accompanied by a NYSE ticker symbol change, from $HLS to "EHC". Beginning in 1Q18, both business segments will begin transitioning to the Encompass Health name.

$MDT {{ '2017-07-10T15:43:07+0000' | timeago}} • Announcement

$MDT announced the expanded FDA approval of the self-expanding CoreValve Evolut transcatheter aortic valve replacement platform to include patients with symptomatic severe aortic stenosis who are at an intermediate risk for open-heart surgery.

$EVHC {{ '2017-07-05T14:28:39+0000' | timeago}} • Announcement

$EVHC unit Envision Physician Services acquired multi-specialty group Infinity Healthcare, Inc., headquartered in Wisconsin. No other terms were disclosed.

Recent Transcripts

ABT (Abbott Laboratories)
Thursday, July 20 2017 - 1:00pm
MDT (Medtronic plc)
Thursday, May 25 2017 - 12:00pm
PTLA (Portola Pharmaceuticals, Inc.)
Monday, May 8 2017 - 8:30pm
FVE (Five Star Quality Care Inc.)
Friday, May 5 2017 - 2:00pm
SEM (Select Medical Holdings Corporation)
Friday, May 5 2017 - 1:00pm
SYN (Synthetic Biologics Inc.)
Thursday, May 4 2017 - 8:30pm
MD (MEDNAX, Inc.)
Thursday, May 4 2017 - 2:00pm
KND (Kindred Healthcare Inc.)
Thursday, May 4 2017 - 1:00pm
FMS (Fresenius Medical Care AG & Co. KGAA)
Wednesday, May 3 2017 - 1:30pm
EVHC (Envision Healthcare Holdings, Inc.)
Tuesday, May 2 2017 - 9:00pm
HCA (HCA Holdings, Inc.)
Tuesday, May 2 2017 - 3:00pm
THC (Tenet Healthcare Corp.)
Tuesday, May 2 2017 - 2:00pm
HLS (HEALTHSOUTH Corp.)
Friday, April 28 2017 - 1:00pm
UHS (Universal Health Services Inc.)
Wednesday, April 26 2017 - 1:00pm
ABT (Abbott Laboratories)
Wednesday, April 19 2017 - 1:00pm
FVE (Five Star Quality Care Inc.)
Friday, March 3 2017 - 3:00pm
SYN (Synthetic Biologics Inc.)
Thursday, March 2 2017 - 9:30pm
UHS (Universal Health Services Inc.)
Wednesday, March 1 2017 - 2:00pm
EVHC (Envision Healthcare Holdings, Inc.)
Tuesday, February 28 2017 - 10:00pm
PTLA (Portola Pharmaceuticals, Inc.)
Tuesday, February 28 2017 - 9:30pm

AlphaGraphics you may like